Perigon Wealth Management »

Takeda Pharmaceutical shares owned by Perigon Wealth Management

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Perigon Wealth Management from 13F filings

Historical chart of Perigon Wealth Management investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Perigon Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Perigon Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $166k 12k 13.89
2023-12-31 $156k 11k 14.27
2023-09-30 $172k 11k 15.47
2020-12-31 $38k 2.1k 18.23

More positions owned by Perigon Wealth Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Occidental Petroleum Corporation (OXY)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Home Depot (HD)
Meta Platforms Cl A (META)
Ishares Tr Core Total Usd (IUSB)

View all positions for Perigon Wealth Management

Top funds holding Takeda Pharmaceutical

Millennium Management
Goldman Sachs Group
Brandes Investment Partners
Arrowstreet Capital, Limited Partnership
Polygon Management
Managed Asset Portfolios
Van Eck Associates Corp.
Causeway Capital Management
Y.D. More Investments
Jane Street
Citadel Advisors
Bank of America Corporation
Wells Fargo & Company
Natixis Asset Management Advisors
Nomura Holdings

View all funds holding Takeda Pharmaceutical